Background: High-quality epidemiologic data worldwide are needed to improve our understanding of disease risk, support health policy to meet the diverse needs of people with multiple sclerosis (MS) and support advocacy efforts. Objectives: The Atlas of MS is an open-source global compendium of data regarding the epidemiology of MS and the availability of resources for people with MS reported at country, regional and global levels. Methods: Country representatives reported epidemiologic data and their sources via survey between September 2019 and March 2020, covering prevalence and incidence in males, females and children, and age and MS type at diagnosis. Regional analyses and comparisons with 2013 data were conducted. Results: A total o...
Objective: To generate a national multiple sclerosis (MS) prevalence estimate for the United States ...
Background Multiple sclerosis is the most common inflammatory neurological disease in young adult...
Background:We need high-quality data to assess the determinants for COVID-19 severity in people with...
Background: High-quality epidemiologic data worldwide are needed to improve our understanding of dis...
Introduction: Worldwide, incidence and prevalence of multiple sclerosis (MS) have increased over the...
International audienceMultiple sclerosis (MS) is the most frequently seen demyelinating disease, wit...
Background: A debate surrounding multiple sclerosis epidemiology has centred on time-related incide...
Objective: Considerable gaps exist in knowledge regarding the prevalence of neurologic diseases, suc...
Background: When population-based databases are unavailable, nationwide assessments of the disease b...
Background: Multiple sclerosis (MS) is a common neurologic autoimmune disorder. We have used a newly...
Objective: To generate a national multiple sclerosis (MS) prevalence estimate for the United States ...
Background Multiple sclerosis is the most common inflammatory neurological disease in young adult...
Background:We need high-quality data to assess the determinants for COVID-19 severity in people with...
Background: High-quality epidemiologic data worldwide are needed to improve our understanding of dis...
Introduction: Worldwide, incidence and prevalence of multiple sclerosis (MS) have increased over the...
International audienceMultiple sclerosis (MS) is the most frequently seen demyelinating disease, wit...
Background: A debate surrounding multiple sclerosis epidemiology has centred on time-related incide...
Objective: Considerable gaps exist in knowledge regarding the prevalence of neurologic diseases, suc...
Background: When population-based databases are unavailable, nationwide assessments of the disease b...
Background: Multiple sclerosis (MS) is a common neurologic autoimmune disorder. We have used a newly...
Objective: To generate a national multiple sclerosis (MS) prevalence estimate for the United States ...
Background Multiple sclerosis is the most common inflammatory neurological disease in young adult...
Background:We need high-quality data to assess the determinants for COVID-19 severity in people with...